|
[1]LINDKVIST B,BENITO de VALLE M,GULLBERG B,et al.Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden[J].Hepatology,2010,52(2):571-577.
|
|
[2]BAMBHA K,KIM WR,TALWALKAR J,et al.Incidence,clinical spectrum,and outcomes of primary sclerosing cholangitis in a United Statescommunity[J].Gastroenterology,2003,125(5):1364-1369.
|
|
[3]KAPLAN GG,LAUPLAND KB,BUTZNER D,et al.The burden of large and small duct primary sclerosing cholangitis in adults and children:a population-based analysis[J].Am J Gastroenterol,2007,102(5):1042-1049.
|
|
[4]BOONSTRA K,BEUERS U,PONSIOEN CY.Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis:a systematic review[J].J Hepatol,2012,56(5):1181-1188.
|
|
[5]MOLODECKY NA,KAREEMI H,PARAB R,et al.Incidence of primary sclerosing cholangitis:a systematic review and meta-analysis[J].Hepatology,2011,53(5):1590-1599.
|
|
[6]KOCHHAR R,GOENKA MK,DAS K,et al.Primary sclerosing cholangitis:an experience from India[J].J Gastroenterol Hepatol,1996,11(5):429-433.
|
|
[7]KINGHAM JG,KOCHAR N,GRAVENOR MB.Incidence,clinical patterns,and outcomes of primary sclerosing cholangitis in South Wales,United Kingdom[J].Gastroenterology,2004,126(7):1929-1930.
|
|
[8]ANG TL,FOCK KM,NG TM,et al.Clinical profile of primary sclerosing cholangitis in Singapore[J].J Gastroenterol Hepatol,2002,17(8):908-913.
|
|
[9]TAKIKAWA H,TAKAMORI Y,TANAKA A,et al.Analysis of388 cases of primary sclerosing cholangitis in Janpan;Presence of a subgroup without pancreatic involvement in older patients[J].Hepatol Res,2004,29(3):153-159.
|
|
[10]BENITO de VALLE M,RAHMAN M,LINDKVIST B,et al.Factors that reduce health-related quality of life in patients with primary sclerosing cholangitis[J].Clin Gastroenterol Hepatol,2012,10(7):769-775.
|
|
[11]TISCHENDORF JJ,HECKER H,KRGER M,et al.Characterization,outcome,and prognosis in 273 patients with primary sclerosing cholangitis:a single center study[J].Am J Gastroenterol,2007,102(1):107-114.
|
|
[12]STANICH PP,BJRNSSON E,GOSSARD AA,et al.Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis[J].Dig Liver Dis,2011,43(4):309-313.
|
|
[13] MENDES FD,JORGENSEN R,KEACH J,et al.Elevated serum IgG 4 concentration in patients with primary sclerosing cholangitis[J].Am J Gastroenterol,2006,101(9):2070-2075.
|
|
[14]SCHULTE-PELKUM J,RADICE A,NORMAN GL,et al.Novel clinical and diagnostic aspects of antineutrophil cytoplasmic antibodies[J].J Immunol Res,2014,2014:185416.
|
|
[15]PLEVY S.Do serological markers and cytokines determine the indeterminate?[J].J Clin Gastroenterol,2004,38(5 Suppl 1):s51-s56.
|
|
[16]FREEMAN ML,NELSON DB,SHERMAN S,et al.Complications of endoscopic biliary sphincterotomy[J].N Engl J Med,1996,335(13):909-918.
|
|
[17]BANGARULINGAM SY,GOSSARD AA,PETERSEN BT,et al.Complications of endoscopic retrograde cholangiopancreatography inprimary sclerosing cholangitis[J].Am J Gastroenterol,2009,104(4):855-860.
|
|
[18]MOFF SL,KAMEL IR,EUSTACE J,et al.Diagnosis of primary sclerosing cholangitis:a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography[J].Gastrointest Endosc,2006,64(2):219-223.
|
|
[19]DAVE M,ELMUNZER BJ,DWAMENA BA,et al.Primary sclerosing cholangitis:meta-analysis of diagnostic performance of MR cholangiopancreatography[J].Radiology,2010,2569(2):387-396.
|
|
[20]BERSTAD AE,AABAKKEN L,SMITH HJ,et al.Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis[J].Clin Gastroenterol Hepatol,2006,4(4):514-520.
|
|
[21]PORTMANN B,ZEN Y.Inflammatory disease of the bile ductscholangiopathies:liver biopsy challenge and clinicopathological correlation[J].Histopathology,2012,60(2):236-248.
|
|
[22]TABIBIAN JH,LINDOR KD.Ursodeoxycholic acid in primary sclerosing cholangitis:if withdrawal is bad,then administration is good(right?)[J].Hepatology,2014,60(3):785-788.
|
|
[23]OLSSON R,BOBERG KM,de MUCKADELL OS,et al.Highdose ursodeoxycholic acid in primary sclerosing cholangitis:a 5-year multicenter,randomized,controlled study[J].Gastroenterology,2005,129(5):1464-1472.
|
|
[24]WUNSCH E,TROTTIER J,MILKIEWICZ M,et al.Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis[J].Hepatology,2014,60(3):931-940.
|
|
[25]KAYA M,PETERSEN BT,ANGULO P,et al.Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis[J].Am J Gastroenterol,2001,96(4):1059-1066.
|
|
[26]ALJIFFRY M,RENFREW PD,WALSH MJ,et al.Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitis[J].HPB(Oxford),2011,13(2):79-90.
|
|
[27]CHAPMAN MH,WEBSTER GJ,BANNOO S,et al.Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis:a 25-year single-centre experience[J].Eur J Gastroenterol Hepatol,2012,24(9):1051-1058.
|
|
[28]BALUYUT AR,SHERMAN S,LEHMAN GA,et al.Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis[J].Gastrointest Endosc,2001,53(3):308-312.
|
|
[29]STIEHL A,RUDOLPH G,KLTERS-PLACHKY P,et al.Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid:outcome after endoscopic treatment[J].J Hepatol,2002,36(2):151-156.
|
|
[30]van MILLIGEN de WIT AW,van BRACHT J,RAUWS EA,et al.Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis[J].Gastrointest Endosc,1996,44(2):293-299.
|
|
[31]ANDRIULLI A,LOPERFIDO S,NAPOLITANO G,et al.Incidence rates of post-ERCP complications:a systematic survey of prospective studies[J].Am J Gastroenterol,2007,102(8):1781-1788.
|
|
[32]HEIF M,YEN RD,SHAN RJ.ERCP with probe-based confocal laser endomicroscopy for the evaluation of dominant biliary stenoses in primary sclerosing cholangitis patients[J].Dig Dis Sci,2013,58(7):2068-2074.
|
|
[33]KIM JH,BYUN JH,LEE SJ,et al.Differential diagnosis of sclerosing cholangitis with autoimmune pancreatitis and periductal infiltrating cancer in the common bile duct at dynamic CT,endoscopic retrograde cholangiography and MR cholangiography[J].Eur Radiol,2012,22(11):2502-2513.
|
|
[34]KATO T,KOMORI A,BAE SK,et al.Concurrent systemic AA amyloidosis can discriminate primary sclerosing cholangitis from IgG 4-associated cholangitis[J].World J Gastroenterol,2012,18(2):192-196.
|
|
[35]ENNS R,ELOUBEIDI MA,MERGENER K,et al.Predictors of successful clinical and laboratory outcomes in patients with primary sclerosing cholangitis undergoing endoscopic retrograde cholangiopancreatography[J].Can J Gastroenterol,2003,17(4):243-248.
|
|
[36]YIMAM KK,BOWLUS CL.Diagnosis and classification of primary sclerosing cholangitis[J].Autoimmun Rev,2014,13(4-5):445-450.
|
|
[37]PONSIOEN CY,VROUENRAETS SM,PRAWIRODIRDJO W,et al.Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population[J].Gut,2002,51(4):562-566.
|
|
[38]CAMPSEN J,ZIMMERMAN MA,TROTTER JF,et al.Clinically recurrent primary sclerosing cholangitis following liver transplantation:a time course[J].Liver Transpl,2008,14(2):181-185.
|
|
[39]ANGULO P,MAOR-KENDLER Y,LINDOR KD.Small-duct primary sclerosing cholangitis:a long-term follow-up study[J].Hepatology,2002,35(6):1494-1500.
|
|
[40]BOONSTRA K,WEERSMA RK,van ERPECUM KJ,et al.Population-based epidemiology,malignancy risk,and outcome of primary sclerosing cholangitis[J].Hepatology,2013,58(6):2045-2055.
|
|
[41]KAYA M,ANGULO P,LINDOR KD.Overlap of autoimmune hepatitis and primary sclerosing cholangitis:an evaluation of a modified scoring system[J].J Hepatol,2000,33(4):537-542.
|
|
[42]van BUUREN HR,van HOOGSTRATEN HJE,TERKIVATAN T,et al.High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis[J].J Hepatol,2000,33(4):543-548.
|
|
[43]AL-CHALABI T,PORTMANN BC,BERNAL W,et al.Autoimmune hepatitis overlap syndromes:an evaluation of treatment response,long-term outcome and survival[J].Aliment Pharmacol Ther,2008,28(2):209-220.
|
|
[44]BOBERG KM,FAUSA O,HAALAND T,et al.Features of autoimmune hepatitis in primary sclerosing cholangitis:an evaluation of114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis[J].Hepatology,1996,23(6):1369-1376.
|
|
[45]OHARA H,OKAZAKI K,TSUBOUCHI H,et al.Clinical diagnostic criteria of IgG 4-related sclerosing cholangitis 2012[J].J Hepatobiliary Pancreat Sci,2012,19(5):536-542.
|
|
[46]GHAZALE A,CHARI ST,ZHANG L,et al.Immunoglobulin G4-associated cholangitis:clinical profile and response to therapy[J].Gastroenterology,2008,134(3):706-715.
|
|
[47]WEBSTER GJ,PEREIRA SP,CHAPMAN RW,et al.Autoimmune pancreatitis/IgG 4-associated cholangitis and primary sclerosing cholangitis-overlapping or separate diseases?[J].J Hepatol,2009,51(2):398-402.
|
|
[48]BERNSTEIN CN,BLANCHARD JF,RAWSTHORNE P,et al.The prevalence of extraintestinal diseases in inflammatory bowel disease:a population-based study[J].Am J Gastroenterol,2001,96(4):1116-1122.
|
|
[49]CLAESSEN MM,VLEGGAAR FP,TYTGAT KM,et al.High lifetime risk of cancer in primary sclerosing cholangitis[J].J Hepatol,2009,50(1):158-164.
|
|
[50]HIRSCHFIELD GM,KARLSEN TH,LINDOR KD,et al.Primary sclerosing cholangitis[J].Lancet,2013,382(9904):1587-1599.
|
|
[51]NAKAZAWA T,NAITOH I,HAYASHI K,et al.Inflammatory bowel disease of primary sclerosing cholangitis:a distinct entity?[J].World J Gastroenterol,2014,20(12):3245-3254.
|
|
[52]BOONSTRA K,van ERPECUM KJ,van NIEUWKERK KM,et al.Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease[J].Inflamm Bowel Dis,2012,18(12):2270-2276.
|
|
[53]KARLSEN TH,SCHRUMP E,BOBERG KM.Gallbladder polyps in primary sclerosing cholangitis:not so benign[J].Curr Opin Gastroenterol,2008,24(3):395-399.
|
|
[54]SOETIKNO RM,LIN OS,HEIDENREICH PA,et al.Increased risk of colorectal neoplasia in patients with primarys clerosing cholangitis and ulcerative colitis:a meta-analysis[J].Gastrointest Endosc,2002,56(1):48-54.
|
|
[55]BURAK K,ANGULO P,PASHA TM,et al.Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis[J].Am J Gastroenterol,2004,99(3):523-526.
|
|
[56]IMAM MH,THACKERAY EW,LINDOR KD.Colonic neoplasia in young patienls with inflammatory bowel disease and primary sclerosing cholangitis[J].Colorectal Dis,2013,15(2):198-203.
|
DownLoad: